Explore Your Local Site

Looks like you've landed on our   site. Let's take you home:    

Please note that the content and products on the    site might not be available in your region.

 

  Homepage
Continue on the current website:  

 

CINA-LVO

Providing rapid automatic analysis of images and highlighting of cases with detected LVO and real-time triage and prioritization, CINA-LVO leverages deep learning to help physicians workload and designed to improve patient outcomes.

Inquire Now

Avicenna
  • Large Vessel Occlusion
  • CT
  • Head
  • Contrast
  • Triage

A.I. Powered LVO triage application

CINA image processing applications provide a case level notification in case of suspected positive findings. This notification can be used by the 3rd party platform to flag series in the platform's worklist to assist trained radiologists in workflow triage by flagging and communicating suspected positive findings of lntracranial Hemorrhage (ICH) and large vessel occlusion (LVO).

yellow arrow

>90% overall performance (Sensitivity & Specificity)1

1Avicenna, AI Solutions for Neurovascular Pathologies. Retrieved on March 27, 2023, from https://avicenna.ai/solutions/head/

 

    Automated Detection of Suspected LVO

    Automated Detection & Alert of Suspected LVO

    The device is intended to assist hospital networks and trained radiologists in workflow triage by flagging and communicating suspected positive findings of CT angiographies of the head for large vessel occlusion (LVO).

    Highlights cases with suspected LVO

    Analyze images and highlights cases with suspected LVO

    The CINA-LVO triage application's mean "time-to­ notification" is estimated to be 34.7 seconds. This demonstrates a substantial equivalence of the CINA­ LVO triage application effectiveness when compared to the predicate device whose mean time was estimated to be 7.32 minutes.

    References

    References

    1. AV-DP CINA 10 013 SUM USER PF VO 2 EN US
    2. FDA premarket notification K200855

    What customers are saying

    In a busy practice, radiologists are expected to interpret exams quickly and accurately. The Avicenna software solution provides an Al-assisted preliminary review of all exams, helping to prioritize patients with positive findings and optimize our clinical workflow. In addition, the extra "set of eyes" provided by the Al software improves our overall confidence and efficiency."

    Daniel Chow
    Radiologist and Director at UCI Health Center for Al in Diagnostic Medicine

    May not reflect a typical user experience; actual results may vary.
    Dr. Daniel Chow has a financial interest in this app vendor

    Request a demo

    See Ahead for Yourself

    Inquire now
    LinkedIn LinkedIn
    Alt tag

    © 2024 Bayer

    The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

    BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners.

    This is intended to provide information for healthcare professionals and other relevant decision makers in the US, European Union, United Kingdom and Switzerland. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

     

    Calantic is ISO 27001 certified. The product Calantic Viewer has CE marking (CE2797). Complies with medical device legislation. Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information. The operating instructions of the product Calantic Viewer can be found on https://www.radiology.bayer.com/manuals

     

    You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

    Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

     

    Last Updated: April 2024

    Bayer Logo